Meeting Challenges and Exceeding Targets in Genetics-Based Clinical Trials
A guide to finding success and navigating the challenges that come with developing and implementing clinical trials for genetic diseases
The number of genetics-based clinical trials is growing rapidly – U.S. spending on orphan drugs has topped $40 billion and half of clinical trials today are collecting biomarker and genetic data. Despite significant progress, incorporating genetic data into clinical trials still presents a great deal of challenges for sponsors and CROs, especially as they struggle with the added concerns of patient identification and enrollment, guidelines around use of genetic test results, and more.
In this ~20-minute on-demand webinar, InformedDNA explores how to address and overcome challenges in genetics-based clinical trials. Topics covered will include:
- Effective patient identification
- Strengthening patient engagement and retention
- Collection, use, and disclosure of genetic data
- Planning for a post-market environment
Register now to view the on-demand webinar.
InformedDNA is the authority on the appropriate use of genetic testing. We leverage the country’s largest, independent, full-time staff of board-certified genetics specialists to ensure access to the highest quality genetics expertise and services. Key offerings for sponsors and CROs include support for clinical trial design, recruitment, enrollment and engagement, clinical genetic counseling, and test facilitation and interpretation services.